Clinical Effect of Percutaneous Cholangiometer in the Diagnosis of Early Neonatal Jaundice
Objective:To explore the value of using percutaneous cholerometer in the diagnosis of early neonatal jaundice.Methods:A study was conducted on 80 cases of early neonatal jaundice admitted to our hospital from October 2019 to January 2023 using an Excel spreadsheet.All cases were tested using a fully automated biochemical analyzer and a percutaneous cholangiometer.The detection results,positive detection rates,and diagnostic efficacy of each protocol were analyzed.Results:Bilirubin value measured by percutaneous cholangiometer(151.24±27.62)μmol/L,compared with the results of the fully automated biochemical analyzer,there was no statistically significant difference(P>0.05);75 cases were detected as positive by percutaneous cholangiometer,accounting for 93.75%,and 76 cases were detected as positive by fully automated biochemical analyzer,accounting for 95.00%(76/80);The sensitivity of the percutaneous cholangiometer was 98.67%,the accuracy was 97.50%,and the specificity was 80.00%.There was no statistically significant difference in comparison with the results of the fully automated biochemical analyzer(P>0.05).Conclusion:The high sensitivity and specificity of percutaneous choliometer in the diagnosis of early neonatal jaundice and the non-invasive nature of this scheme can be widely used in the screening and diagnosis of early neonatal jaundice.
early stageneonatal jaundicediagnosispercutaneous cholangiometersensitivity